• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    4/13/23 12:24:13 PM ET
    $AMST
    $AUUD
    $BBAI
    $BFRG
    Computer Software: Prepackaged Software
    Technology
    EDP Services
    Technology
    Get the next $AMST alert in real time by email

    Gainers

    • CXApp Inc. (NASDAQ:CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.
    • SAB Biotherapeutics, Inc. (NASDAQ:SABS) gained 71% to $0.6587 after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza.
    • Auddia Inc. (NASDAQ:AUUD) jumped 68.2% to $0.8917 after gaining more than 10% on Wednesday.
    • Ocean Biomedical, Inc. (NASDAQ:OCEA) jumped 50% to $6.76. Ocean Biomedical’s co-founder, Jonathan Kurtis, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S. patent application covering a therapeutic and prophylactic monoclonal antibody that kills falciparum malaria parasites.
    • Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) shares jumped 35.5% to $3.74 after Searchlight Capital and BCI submitted a non-binding proposal to acquire all outstanding shares of Consolidated Communications not owned by Searchlight or BCI for $4 per share.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) surged 31.1% to $1.18 after the company announced a $15 million private placement of equity.
    • Amesite Inc. (NASDAQ:AMST) gained 30.7% to $4.64.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) rose 29.3% to $0.1699.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) rose 23% to $0.1427.
    • Inuvo, Inc. (NYSE:INUV) gained 19.1% to $0.3399.
    • Predictive Oncology Inc. (NASDAQ:POAI) gained 18.4% to $0.3261. Predictive Oncology recently reported collaboration with Integra Therapeutics to advance gene therapy.
    • Xos, Inc. (NASDAQ:XOS) gained 17.3% to $0.6803.
    • ImmunityBio, Inc. (NASDAQ:IBRX) rose 17% to $1.80.
    • ContraFect Corporation (NASDAQ:CFRX) jumped 16.8% to $1.18. Maxim Group upgraded ContraFect from Hold to Buy and announced a $3 price target.
    • CleanSpark, Inc. (NASDAQ:CLSK) rose 15.6% to $3.77. CleanSpark announced the purchase of 45,000 units of the Antminer S19 XP bitcoin mining machines.
    • Sana Biotechnology, Inc. (NASDAQ:SANA) gained 15% to $4.32.
    • National CineMedia, Inc. (NASDAQ:NCMI) surged 14.1% to $0.5046 after jumping around 115% on Wednesday. The company filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas. The company announced a series of debt restructuring transactions likely to strengthen its balance sheet meaningfully and position it for long-term growth.
    • Editas Medicine, Inc. (NASDAQ:EDIT) rose 13.8% to $7.24.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares gained 13.6% to $3.1681.
    • Tupperware Brands Corporation (NYSE:TUP) jumped 13.5% to $1.4985.
    • WW International, Inc. (NASDAQ:WW) rose 13.3% to $7.35.
    • Iris Energy Limited (NASDAQ:IREN) rose 12.9% to $4.1214.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) jumped 9.5% to $10.90.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) gained 8% to $0.1810.
    • Getaround, Inc. (NYSE:GETR) gained 7.6% to $0.2718. Getaround recently said it sees preliminary FY22 total revenues of $59 million to $60 million.

    Losers

    • GlucoTrack, Inc. (NASDAQ:GCTK) shares dropped 50% to $1.3516 after the company priced 7,352,942 share offering at $1.36 per share.
    • ViewRay, Inc. (NASDAQ:VRAY) fell 32.1% to $2.0450 after the company lowered its FY23 revenue guidance to approximately 0%-15% growth compared to its guidance of 25%-40% growth and announced it will explore strategic alternatives to maximize shareholder value.
    • Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) fell 20% to $6.65 after the company issued weak Q1 guidance and announced CEO Jon Barker will retire.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) shares fell 19.6% to $1.1210. HeartCore Enterprises shares jumped over 56% on Wednesday after the company announced it signed its tenth Go IPO contract.
    • Liquid Media Group Ltd. (NASDAQ:YVR) dropped 19.1% to $0.1552.
    • Altamira Therapeutics Ltd. (NASDAQ:CYTO) fell 18.1% to $1.7201. Altamira Therapeutics shares jumped 59% on Wednesday after the company announced the publication of results from its Phase 2 trial with AM-125 in acute vestibular syndrome in a leading peer reviewed journal..
    • Rosecliff Acquisition Corp I (NASDAQ:RCLF) dropped 14.3% to $11.66.
    • iMedia Brands, Inc. (NASDAQ:IMBI) fell 13.6% to $0.3621. The company reported worse-than-expected Q4 EPS and sales results.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) fell 13.4% to $0.7556. Creative Medical Technology shares jumped over 85% on Wednesday after the company announced one-year follow-up data and significant efficacy using CELZ-001 to treat patients with Type 2 Diabetes without any serious adverse effects reported.
    • Cyxtera Technologies, Inc. (NASDAQ:CYXT) dropped 13.3% to $0.3454.
    • Rent the Runway, Inc. (NASDAQ:RENT) fell 13.3% to $2.72 following downbeat quarterly sales.
    • Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) dropped 13.1% to $5.33.
    • PARTS iD, Inc. (NYSE:ID) fell 11.5% to $0.2301.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) fell 11.2% to $1.67.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) dipped 10% to $1.0801.
    • WeTrade Group, Inc. (NASDAQ:WETG) fell 9.7% to $0.1626 after dropping 7% on Wednesday.
    • Infosys Limited (NYSE:INFY) dropped 9% to $15.53 after the company reported worse-than-expected Q4 financial results.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) shares dropped 7.7% to $28.72 after surging over 88% on Wednesday.
    • T Stamp Inc. (NASDAQ:IDAI) fell 7.5% to $3.5201 after jumping 100% on Wednesday. Trust Stamp announced a Notice of Allowance for three new U.S patent related to its artificial intelligence based biometric authentication technology.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) shares dropped 7.5% to $2.85. BigBear.Ai filed for mixed shelf.
    • Kemper Corporation (NYSE:KMPR) fell 6.5% to $53.45.
    • Harley-Davidson, Inc. (NYSE:HOG) shares fell 4% to $35.85 in pre-market trading after the company disclosed a CFO transition. The company’s CFO Gina Goetter will step down from her role at the end of April. Hasbro, Inc. (NASDAQ:HAS), meanwhile, named Gina Goetter as its CFO.

    Now Read This: Bitcoin Jumps Above $30,000 Following PPI Data; WOO Network Emerges As Top Gainer

    Get the next $AMST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMST
    $AUUD
    $BBAI
    $BFRG

    CompanyDatePrice TargetRatingAnalyst
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Hasbro Inc.
    $HAS
    2/25/2026$118.00Outperform
    BNP Paribas Exane
    Infosys Limited
    $INFY
    2/23/2026$14.31Buy → Hold
    Jefferies
    Harley-Davidson Inc.
    $HOG
    2/12/2026$30.00 → $25.00Buy
    DA Davidson
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Kemper Corporation
    $KMPR
    2/5/2026Mkt Outperform → Mkt Perform
    Citizens
    IREN Limited
    $IREN
    1/13/2026$80.00Sell → Buy
    H.C. Wainwright
    CleanSpark Inc.
    $CLSK
    1/13/2026$22.50Outperform
    Northland Capital
    More analyst ratings

    $AMST
    $AUUD
    $BBAI
    $BFRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Rent the Runway, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. ("Rent the Runway") (NASDAQ:RENT) announced today the grant of an inducement award to Dhiren Fonseca, the Executive Chair of Rent the Runway's Board of Directors, effective February 27, 2026.  The inducement award is comprised of 802,395 restricted stock units in respect of Rent the Runway's Class A common stock ("RSUs"). The RSUs will vest as to 25% of the shares underlying the RSUs on October 28, 2026, with the remaining 75% of the RSUs vesting in equal quarterly installments through October 28, 2029, subject to continued service through the applicable vesting date. The inducement award was unanimously approved by Rent t

    2/27/26 9:00:00 AM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMST
    $AUUD
    $BBAI
    $BFRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simon Barry J. sold $900,788 worth of shares (75,000 units at $12.01), decreasing direct ownership by 3% to 2,850,821 units (SEC Form 4)

    4 - ImmunityBio, Inc. (0001326110) (Issuer)

    2/26/26 8:12:26 PM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Cocks Christian P covered exercise/tax liability with 8,030 shares, decreasing direct ownership by 3% to 250,967 units (SEC Form 4)

    4 - HASBRO, INC. (0000046080) (Issuer)

    2/26/26 7:27:44 PM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    EVP, CLO and Corp Secretary Sibley Tarrant L. covered exercise/tax liability with 1,680 shares, decreasing direct ownership by 3% to 61,055 units (SEC Form 4)

    4 - HASBRO, INC. (0000046080) (Issuer)

    2/26/26 7:22:15 PM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    $AMST
    $AUUD
    $BBAI
    $BFRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    BNP Paribas Exane initiated coverage on Hasbro with a new price target

    BNP Paribas Exane initiated coverage of Hasbro with a rating of Outperform and set a new price target of $118.00

    2/25/26 8:51:16 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    Infosys downgraded by Jefferies with a new price target

    Jefferies downgraded Infosys from Buy to Hold and set a new price target of $14.31

    2/23/26 8:32:07 AM ET
    $INFY
    EDP Services
    Technology

    $AMST
    $AUUD
    $BBAI
    $BFRG
    SEC Filings

    View All

    SEC Form PRE 14A filed by NeuroOne Medical Technologies Corporation

    PRE 14A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)

    2/27/26 4:31:17 PM ET
    $NMTC
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Rent the Runway Inc.

    S-8 - Rent the Runway, Inc. (0001468327) (Filer)

    2/27/26 8:30:10 AM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Amendment: National CineMedia Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K/A - National CineMedia, Inc. (0001377630) (Filer)

    2/27/26 7:49:20 AM ET
    $NCMI
    Advertising
    Consumer Discretionary

    $AMST
    $AUUD
    $BBAI
    $BFRG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney bought $643,464 worth of shares (29,057 units at $22.14) (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    11/20/25 4:01:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Tucci Michael D bought $140,500 worth of shares (50,000 units at $2.81), increasing direct ownership by 216% to 73,113 units (SEC Form 4)

    4 - SPORTSMAN'S WAREHOUSE HOLDINGS, INC. (0001132105) (Issuer)

    10/6/25 6:58:04 PM ET
    $SPWH
    Other Specialty Stores
    Consumer Discretionary

    PRESIDENT AND CEO Stone Paul bought $188,359 worth of shares (68,279 units at $2.76), increasing direct ownership by 7% to 1,110,602 units (SEC Form 4)

    4 - SPORTSMAN'S WAREHOUSE HOLDINGS, INC. (0001132105) (Issuer)

    10/3/25 6:10:15 PM ET
    $SPWH
    Other Specialty Stores
    Consumer Discretionary

    $AMST
    $AUUD
    $BBAI
    $BFRG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMST
    $AUUD
    $BBAI
    $BFRG
    Leadership Updates

    Live Leadership Updates

    View All

    Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer

    SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Brian Piper as Executive Vice President, Chief Financial Officer. Mr. Piper brings to Sana a breadth of biopharmaceutical financial and operational expertise with over 25 years of experience in various positions in the industry. Mr. Piper was most recently CFO of Scorpion Therapeutics and its post-acquisition spin-off, Antares Therapeutics. "I am thrilled to welcome Brian to Sana and to our leadership team," said Steve Harr, President and Chief Executive Officer of Sana. "He brings deep exper

    2/17/26 9:00:00 AM ET
    $SANA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    IREN Appoints John Gross as Chief Innovation Officer

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced the appointment of John Gross as Chief Innovation Officer, a newly established role responsible for leading engineering standards, thermal architecture, and commissioning across IREN's next-generation data centers. Mr. Gross is a globally recognized leader in data center engineering, with two decades of industry experience and deep expertise in high-density and liquid-cooled data center design. He serves as Vice Chair of committees within ASHRAE (American Society of Heating, Refrigerating and Air-Conditioning Engineers), which develops global standards for high-density and liquid-cooled data ce

    2/17/26 5:00:50 AM ET
    $IREN
    EDP Services
    Technology

    Inuvo Appoints Rob Buchner as Chairman and Chief Executive Officer

    LITTLE ROCK, Ark., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE:INUV), a leading provider of artificial intelligence-driven data and advertising technology solutions, today announced the appointment of Rob Buchner as Chairman of the Board and Chief Executive Officer, effective February 1, 2026. Throughout 2025, Buchner worked closely within Inuvo in an advisory, board, and executive capacity. This experience has provided a comprehensive understanding of the company's existing markets, strategy, technology, and growth opportunities. Since joining the executive team as Chief Operating Officer in October of 2025, he has led a comprehensive review of talent, operations, product devel

    1/28/26 4:15:00 PM ET
    $INUV
    Advertising
    Consumer Discretionary

    $AMST
    $AUUD
    $BBAI
    $BFRG
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    MARA Announces Fourth Quarter and Fiscal Year 2025 Results

    Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading energy and digital infrastructure company, today announced its preliminary, unaudited fourth quarter and fiscal year 2025 financial results in a letter to shareholders. Investors are invited to access the fourth quarter 2025 shareholder letter at MARA's website at ir.mara.com. A copy of the letter will also be furnished to the Securities and Exchange Commission on a Form 8-K. MARA will hold a webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) today to discuss these financial results. To register to participate in the conference call, please use

    2/26/26 4:20:00 PM ET
    $MARA
    EDP Services
    Technology

    $AMST
    $AUUD
    $BBAI
    $BFRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology